Ketamine Hcl



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Anaesthesia 18.8%
General Anaesthesia 15.0%
Prophylaxis 12.5%
Induction Of Anaesthesia 8.1%
Product Used For Unknown Indication 6.9%
Tooth Extraction 6.3%
Drug Abuse 5.6%
Sedation 5.0%
Complex Regional Pain Syndrome 4.4%
Pain 2.5%
Epilepsy 1.9%
Maintenance Of Anaesthesia 1.9%
Sedative Therapy 1.9%
Substance Use 1.9%
Analgesic Therapy 1.3%
Arthralgia 1.3%
Depression 1.3%
Drug Resistance 1.3%
Drug Use For Unknown Indication 1.3%
Endotracheal Intubation 1.3%
Hypotension 19.7%
Toxicity To Various Agents 8.2%
Apnoea 6.6%
Drug Abuse 6.6%
Bradycardia 4.9%
Face Oedema 4.9%
Medication Error 4.9%
Unresponsive To Stimuli 4.9%
Cholestasis 3.3%
Convulsion 3.3%
Corneal Oedema 3.3%
Cystitis 3.3%
Death 3.3%
Hepatic Function Abnormal 3.3%
Hypertension 3.3%
Life Support 3.3%
Overdose 3.3%
Pulseless Electrical Activity 3.3%
Suicidal Ideation 3.3%
Suprapubic Pain 3.3%
Secondary
Product Used For Unknown Indication 19.2%
Drug Use For Unknown Indication 16.6%
Pain 11.6%
Anaesthesia 10.1%
Induction Of Anaesthesia 8.1%
General Anaesthesia 5.5%
Analgesic Therapy 4.3%
Sedation 3.9%
Maintenance Of Anaesthesia 2.5%
Cancer Pain 2.2%
Electrolyte Substitution Therapy 2.2%
Arthritis 1.8%
Stupor 1.8%
Hypertension 1.7%
Hypotonia 1.7%
Thrombosis Prophylaxis 1.5%
Prophylaxis 1.4%
Restlessness 1.3%
Premedication 1.2%
Procedural Pain 1.2%
Renal Failure Acute 16.4%
Transaminases Increased 12.3%
Anaphylactic Shock 8.2%
Drug Abuse 5.8%
Somnolence 5.3%
Drug Ineffective 4.7%
Bradycardia 4.1%
Cardiac Arrest 4.1%
Stevens-johnson Syndrome 4.1%
Drug Interaction 3.5%
Posterior Reversible Encephalopathy Syndrome 3.5%
Respiratory Arrest 3.5%
Respiratory Depression 3.5%
Vomiting 3.5%
Acute Hepatic Failure 2.9%
Death 2.9%
Hyperaesthesia 2.9%
Sedation 2.9%
Toxic Epidermal Necrolysis 2.9%
Toxicity To Various Agents 2.9%
Concomitant
Product Used For Unknown Indication 34.9%
Drug Use For Unknown Indication 20.7%
Pain 10.0%
Sedation 6.1%
Anaesthesia 3.6%
Prophylaxis 3.0%
Nausea 2.6%
Induction Of Anaesthesia 2.3%
General Anaesthesia 1.7%
Acute Lymphocytic Leukaemia 1.6%
Convulsion 1.6%
Cardiopulmonary Bypass 1.5%
Hypertension 1.5%
Coronary Artery Bypass 1.3%
Maintenance Of Anaesthesia 1.3%
Analgesic Therapy 1.3%
Cancer Pain 1.3%
Non-hodgkin's Lymphoma 1.2%
Asthma 1.2%
Breast Cancer 1.2%
Strabismus 7.6%
Vomiting 7.6%
Tachycardia 6.8%
Aspartate Aminotransferase Increased 5.9%
Pain 5.9%
Renal Failure 5.9%
Ventricular Tachycardia 5.9%
Rash 5.1%
Somnolence 5.1%
Visual Acuity Reduced 5.1%
Fear 4.2%
Hypotension 4.2%
Injury 4.2%
Nausea 4.2%
Pneumonia 4.2%
Rhabdomyolysis 4.2%
Bronchospasm 3.4%
Disseminated Intravascular Coagulation 3.4%
Hyperbilirubinaemia 3.4%
Oophorectomy 3.4%
Interacting
Cancer Pain 32.6%
Product Used For Unknown Indication 20.9%
General Anaesthesia 9.3%
Pain 9.3%
Renal Cancer Metastatic 9.3%
Anaesthesia 7.0%
Abdominal Pain Upper 2.3%
Complex Regional Pain Syndrome 2.3%
Induction Of Anaesthesia 2.3%
Intraoperative Care 2.3%
Premedication 2.3%
Depressed Level Of Consciousness 20.0%
Drug Interaction 13.3%
General Physical Health Deterioration 13.3%
Somnolence 13.3%
Agitation 6.7%
Areflexia 6.7%
Hepatic Function Abnormal 6.7%
Motor Dysfunction 6.7%
Performance Status Decreased 6.7%
Toxicity To Various Agents 6.7%